Opportunity ID: 356596

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DA-26-009
Funding Opportunity Title: Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 30, 2024
Last Updated Date: Sep 30, 2024
Original Closing Date for Applications: Mar 10, 2026
Current Closing Date for Applications: Mar 10, 2026
Archive Date: Apr 15, 2026
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: For profit organizations other than small businesses
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Special district governments
Independent school districts
Small businesses
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: To promote research investigating protective and pathogenic mechanisms at the nexus of mitochondria function and aging in the context of HIV infection and exposure to addictive substances. We anticipate this foundational knowledge could be leveraged to develop targeted therapies and improve outcomes in people aging with HIV, substance use and addiction.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-26-009.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 356596 Full Announcement-RFA-DA-26-009 -> RFA-DA-26-009-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-I Use for due dates on or after January 25, 2025 PKG00288384 Feb 10, 2025 Mar 10, 2026 View

Package 1

Mandatory forms

356596 RR_SF424_5_0-5.0.pdf

356596 PHS398_CoverPageSupplement_5_0-5.0.pdf

356596 RR_OtherProjectInfo_1_4-1.4.pdf

356596 PerformanceSite_4_0-4.0.pdf

356596 RR_KeyPersonExpanded_4_0-4.0.pdf

356596 PHS398_ResearchPlan_5_0-5.0.pdf

356596 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

356596 RR_Budget_3_0-3.0.pdf

356596 RR_SubawardBudget30_3_0-3.0.pdf

356596 PHS398_ModularBudget_1_2-1.2.pdf

356596 PHS_AssignmentRequestForm_4_0-4.0.pdf

2025-07-13T09:25:25-05:00

Share This Post, Choose Your Platform!

About the Author: